日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors

Cergutuzumab Amunaleukin 与 Atezolizumab 联合治疗癌胚抗原阳性晚期/转移性实体瘤患者

Melero, Ignacio; Tabernero, Josep; Steeghs, Neeltje; Robbrecht, Debbie G J; Peters, Solange; Rizvi, Naiyer A; O'Reilly, Eileen M; Calvo, Emiliano; Eefsen, Rikke L; Leighl, Natasha; Cervantes, Andres; Hafez, Navid; Habigt, Christin; Andersson, Emilia; Dejardin, David; Rossmann, Eva; Martinez Quetglas, Iris; Babitzki, Galina; Duarte, José; Adessi, Celine; Boetsch, Christophe; Evers, Stefan; Charo, Jehad; Teichgräber, Volker; Lassen, Ulrik

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway

转移性前列腺癌患者采用主流基因检测途径的经验

Vlaming, Michiel; Bleiker, Eveline M A; Schijven, Gina; Kiemeney, Lambertus A L M; van Melick, Harm H E; Hunting, Jarmo C B; Noordzij, M Arjen; Beeker, Aart; Somford, Diederik M; van der Poel, Henk G; Wijburg, Carl J; Wijsman, Bart P; Hoekstra, Robert J; van Moorselaar, R Jeroen A; van Bezooijen, Bart P J; Meijer, Richard P; Busstra, Martijn B; van den Berg, H Pieter; Robbrecht, Debbie G J; Doornweerd, Benjamin H J; van Oort, Inge M; Ausems, Margreet G E M

First real-world clinical experience with [(177)Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria

首次在符合VISION和TheraP标准以外的转移性去势抵抗性前列腺癌患者中应用[(177)Lu]Lu-PSMA-I&T进行真实世界临床研究

Ling, Sui Wai; de Lussanet de la Sablonière, Quido; Ananta, Michael; de Blois, Erik; Koolen, Stijn L W; Drexhage, Roosmarijn C; Hofland, Johannes; Robbrecht, Debbie G J; van der Veldt, Astrid A M; Verburg, Frederik A; Brabander, Tessa

Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer

泌尿科医生、肿瘤科医生和执业护士在转移性前列腺癌主流基因检测方面的经验

Vlaming, Michiel; Ausems, Margreet G E M; Kiemeney, Lambertus A L M; Schijven, Gina; van Melick, Harm H E; Noordzij, M Arjen; Somford, Diederik M; van der Poel, Henk G; Wijburg, Carl J; Wijsman, Bart P; Hoekstra, Robert J; van Moorselaar, Reindert J A; van Bezooijen, Bart P J; Meijer, Richard P; Busstra, Martijn B; van den Berg, H Pieter; Robbrecht, Debbie G J; Doornweerd, Benjamin H J; Bleiker, Eveline M A; van Oort, Inge M

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View

常规前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描如何改变目前前列腺癌的治疗方案?多学科视角

Oprea-Lager, Daniela E; van Elst, Tessa; Aluwini, Shafak; Dewulf, Els; der Poel, Henk van; Stoevelaar, Herman; Bangma, Chris H; Beeker, Aart; Boudewijns, Steve; Budiharto, Tom; de Jong, Igle-Jan; de Vries, Kim C; Donswijk, Maarten L; Fütterer, Jurgen J; Hamberg, Paul; Heijmen, Linda; Hoekstra, Robert J; Kerkhofs, Thomas M A; Lavalaye, Jules; Bruin, Daphne Luijendijk-de; Noordzij, Walter; Oving, Irma M; Robbrecht, Debbie G J; Schaake, Eva E; van de Luijtgaarden, Addy C M; van den Bergh, Roderick C N; van den Berkmortel, Franchette; van der Hulle, Tom; van der Mijn, Johannes C K; van Dodewaard-de Jong, Joyce M; van Kruchten, Michel; van Leeuwen, Pim J; van Limbergen, Evert; van Moorselaar, R Jeroen A; van Oort, Inge M; van Roermund, Joep G H; van Soest, Robert J; Veninga, Theo; Vis, André N; Voortman, Jens; Willemse, Peter-Paul M; Yakar, Derya; Mehra, Niven

Carbon footprint and staff demands of surgery and chemoradiation for muscle-invasive bladder cancer

肌层浸润性膀胱癌手术和放化疗的碳足迹和医护人员需求

Rutten, Vera C; Hesseling, Simone A W; Franckena, Martine; Zuiverloon, Tahlita C M; Robbrecht, Debbie G J; IJzerman, Maarten J; Lin, Wenxin; Mes, Daan; Hunfeld, Nicole; Boormans, Joost L

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer

基于基因表达的T细胞-基质富集(TSE)评分可预测尿路上皮癌对免疫检查点抑制剂的反应

Rijnders, Maud; Nakauma-González, J Alberto; Robbrecht, Debbie G J; Gil-Jimenez, Alberto; Balcioglu, Hayri E; Oostvogels, Astrid A M; Aarts, Maureen J B; Boormans, Joost L; Hamberg, Paul; van der Heijden, Michiel S; Szabados, Bernadett E; van Leenders, Geert J L H; Mehra, Niven; Voortman, Jens; Westgeest, Hans M; de Wit, Ronald; van der Veldt, Astrid A M; Debets, Reno; Lolkema, Martijn P

Evidence for phonon hardening in laser-excited gold using x-ray diffraction at a hard x-ray free electron laser

利用硬X射线自由电子激光器的X射线衍射技术,证实了激光激发金中声子硬化现象

Descamps, Adrien; Ofori-Okai, Benjamin K; Bistoni, Oliviero; Chen, Zhijiang; Cunningham, Eric; Fletcher, Luke B; Hartley, Nicholas J; Hastings, Jerome B; Khaghani, Dimitri; Mo, Mianzhen; Nagler, Bob; Recoules, Vanina; Redmer, Ronald; Schörner, Maximilian; Senesky, Debbie G; Sun, Peihao; Tsai, Hai-En; White, Thomas G; Glenzer, Siegfried H; McBride, Emma E

Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma

免疫细胞因子 Simlukafusp Alfa (FAP-IL2v) 与西妥昔单抗联合治疗头颈部鳞状细胞癌患者的 Ib 期研究

Aaron R Hansen, Carlos A Gomez-Roca, Debbie G J Robbrecht, Loic Verlingue, Antoine Italiano, Julie E Bauman, Neeltje Steeghs, Hans Prenen, Jérôme Fayette, James Spicer, Jiaxin Niu, Christin Habigt, Meike Schneider, Stefan Evers, Nassim Sleiman, David Dejardin, Caroline Ardeshir, Daniela Schmid, Chri

Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?

原发性肿瘤是否适合采用生物标志物指导的转移性尿路上皮癌治疗?

Scholtes, Mathijs P; van Leenders, Geert J L H; Robbrecht, Debbie G J; Boormans, Joost L; Zuiverloon, Tahlita C M